About Enhancer
| Enhancer ID: | E_01081 |
| Species: | Homo sapiens |
| Position : | chr5:1320064-1320208   |
| Year: | 2021 |
| Title: | Enhancer release and retargeting activates disease-susceptibility genes. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | cancer |
| PMID: | 34040254 |
| MONDO: | MONDO:0004992 |
| Cell Source: | HEK293T |
| CVCL ID: | CVCL_0063 |
| Cell Type: | transformed cell line |
| Experiment Type: | Enhancer retargeting assay; Functional promoter-tether perturbation assay; Chromatin interaction assay; Cancer mutation analysis |
| High Throughput Method: | Hi-C; ChIA-PET; GRO-seq; WGS |
| Low Throughput Method: | CRISPR/Cas9 promoter deletion; CRISPR knock-in; 4C-seq; qRT-PCR; ChIP-qPCR; Sanger sequencing; CRISPRi |
About Target Gene
| Target gene : | TERT |
About TF
| TF name : | NA |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Overlapping Enhancers (hg19)
No overlapping enhancers found in hg19 at this locus.
Expression of Target Genes for the Enhancer